Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a native American population

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1729-1737

  Tan, Filemon K ^a   Stivers, David N ^b   Foster, Morris W ^c   Chakraborty, Ranajit ^b   Howard, Robert F ^d   Milewicz, Dianna M ^a   Arnett, Frank C ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d Choctaw Nation Indian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLIN; MICROSATELLITE DNA;

ALLELE; ARTICLE; CHROMOSOME 15Q; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE LOCATION; GENE MAPPING; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MARKER GENE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

ALLELES; CHROMOSOMES, HUMAN, PAIR 15; GENOTYPE; HAPLOTYPES; HUMANS; INDIANS, NORTH AMERICAN; MICROFILAMENT PROTEINS; MICROSATELLITE REPEATS; OKLAHOMA; PEDIGREE; PHENOTYPE; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 0031687121     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1729::AID-ART5>3.0.CO;2-8     Document Type: Article

References (59)

1. Medsger TA Jr. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. Philadelphia: Lea and Febiger; 1993. p. 1253-99.
2. Silman A. Epidemiology of scleroderma. Curr Opin Rheumatol 1991;3:967-72.
3. Arnett FC. HLA and autoimmunity in scleroderma (systemic sclerosis). Int Rev Immunol 1995;12:107-28.
4. Reveille JD, Owerbach D, Goldstein R, Moreda R, Isern RA, Arnett FC. Association of polar amino acid sequences at position 26 of the HLA-DQB1 first domain with the anti-centromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest 1992;89:1208-13.
5. Reveille JD, Durban E, MacLeod-St. Clair MJ, Goldstein R, Moreda R, Altman RD, et al. Association of amino acid sequences in the HLA-DQB1 first domain with the anti-topoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992;90:973-80.
6. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuj K. The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993;92:1296-301.
7. Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996;39:1151-60.
8. McGregor AR, Watson A, Yunis E, Pandey JP, Takehara K, Tidwell JT, et al. Familial clustering of scleroderma spectrum disease. Am J Med 1988;84:1023-32.
9. Manolios N, Dunckley H, Chivers T, Brooks P, Englert H. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants. J Rheumatol 1995;22:85-92.
10. Stephens CO, Briggs DC, Whyte J, Artlett CM, Scherbakov AB, Olsen N, et al. Familial scleroderma - evidence for environmental versus genetic trigger. Br J Rheumatol 1994;33:1131-5.
11. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-8.
12. McHugh NJ, Harvey GR, Whyte J, Dorsey JK. Segregation of autoantibodies with disease in monozygotic twin pairs discordant for systemic sclerosis: three further cases. Arthritis Rheum 1995; 38:1845-50.
13. Cook NJ, Silman AJ, Propert J, Cawley MID. Features of systemic sclerosis (scleroderma) in an identical twin pair. Br J Rheumatol 1993;32:926-8.
14. Dustoor MM, Mclnerney MM, Mazanec DJ, Cathcart MK. Abnormal lymphocyte function in scleroderma: a study on identical twins. Clin Immunol Immunopathol 1987;44:20-30.
15. Zorina VJ, Zorin SP. Scleroderma in 5 year old twin girls. Pediatriya 1982;7:69-70.
16. Dubois EL, Chandor S, Friou G, Bischel M. Progressive systemic sclerosis and localized scleroderma (morphea) with positive LE cell test and unusual systemic manifestations compatible with systemic lupus erythematosus: presentation of 14 cases including one set of identical twins, one with scleroderma and the other with SLE. Medicine (Baltimore) 1971;50:199-222.
17. 2-microglobulin (B2m) gene on chromosome 2. Genomics 1993;17: 748-51.
18. Goldstein C, Liaw P, Jimenez SA, Buchberg MA, Siracusa LD. Of mice and Marfan: genetic linkage analyses of the fibrillin genes, FBN1 and FBN2, in the mouse genome. Mamm Genome 1994;5: 696-700.
19. Everett ET, Pablos JL, Harris SE, Leroy EC, Norris JS. The tight-skin (tsk) mutation is closely linked to B2m on mouse chromosome 2. Mamm Genome 1994;5:55-7.
20. Doute RC, Clark SH. Tight-skin (TSK) maps on mouse chromosome 2 within the region of linkage homology with human chromosome 15. Genomics 1994;22:223-5.
21. Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Rheum Dis Clin North Am 1996;22:547-674.
22. Nicklin M, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-a, interleukin-1β and interleukin-1 receptor antagonist genes. Genomics 1994;19:382-4.
23. Peters J, Ball ST. Tight skin-2 (Tsk 2). Mouse News Lett 1986;74: 91-2.
24. Christner PJ, Peters J, Hawkins D, Siracusa LD, Jiménez SA. The tight skin 2 mouse: an animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration. Arthritis Rheum 1995;38:1791-8.
25. Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, et al. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma: association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-70.
26. Houwen RH, Baharloo JS, Blankenship K, Raeymaekers P, Juyn J, Sandkuijl LA, et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet 1994;8:380-6.
27. Hastbacka J, del la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet 1992;2: 204-11.
28. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
29. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1978;3:2303-8.
30. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human thrombospondin gene (THBS1). Nucleic Acids Res 1995;18:7467.
31. Lee B, Godfrey M, Vitale E, Hori H, Mattel M, Sarfarazi M, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 1991;352:330-4.
32. Pereira L, Levran O, Ramirez F, Lynch JR, Sykes B, Pyeritz RE, et al. A molecular approach to the stratification of cardiovascular risk in families with Marfan's syndrome. N Engl J Med 1994;331: 148-53.
33. Barber TD, Morell R, Johnson DH, Asher JH Jr, Friedman TB. A highly informative dinucleotide repeat polymorphism at the D2S211 locus linked to ALPP, FN1 and TNP1. Hum Mol Genet 1993;2:88.
34. Epplen C, Frank G, Gomolka M, Albert E, Nurnberg P, Epplen ET. Dinucleotide repeat polymorphism in the human IL1A gene. Hum Mol Genet 1994;3:1710.
35. Buetow KH, Weber JL, Ludwigsen S, Scherpbier-Heddena T, Duyk GM, Sheffield VC, et al. Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet 1994;6:388-93.
36. Gyapay G, Morisette VA. The 1993-1994 Genethon human genetic linkage map. Nat Genet 1994;7:246-339.
37. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152-4.
38. Maniatis T, Fritsch EF, Sambrook J. Transfer of DNA from agarose gels to nitrocellulose paper. In: Molecular cloning, a laboratory manual. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1982. p. 383.
39. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995;56: 799-810.
40. Slatkin M, Excoffier L. Testing for linkage disequilibrium in genotypic data using the expectation-maximization algorithm. Heredity 1996;76:377-83.
41. Chakraborty R, Srinivasan MR, de Andrade M. Intraclass and interclass correlations of allele sizes within and between loci in DNA typing data. Genet Soc Am 1993;133:411-9.
42. Collins A, Frezal J, Teague J, Morton NE. A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci U S A 1996;93:14771-5.
43. Cavalli-Sforza LL, Bodmer WF. The genetics of human populations. San Francisco: W.H. Freeman; 1971. p. 341-53.
44. Dobyns HF. Their number became thinned: Native American population dynamics in eastern North America. Knoxville: University of Tennessee Press; 1983.
45. Siracusa LD, McGrath R, Ma Q, Moskow JJ, Mane J, Christner PJ, et al. A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1996;6:300-13.
46. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986;103:2499-509.
47. Fleischmajer R. The collagen in scleroderma. Arch Dermatol 1964;89:437-41.
48. Musso LA. A contribution to the pathogenesis of the changes in the collagen-ground substance equilibrium in morphoea (scleroderma). Br J Dermatol 1954;66:377-87.
49. Seville RH. Sclerodermia dermatomyositis (with electronmicrographs). Br J Dermatol 1952;64:467-70.
50. Moren A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, et al. Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J Biol Chem 1994;269:32469-78.
51. Yin W, Smiley E, Germiller J, Mecham RP, Florer JB, Wenstrup RJ, et al. Isolation of a novel latent transforming growth factor-beta binding protein (LTBP-3). J Biol Chem 1995;270:10147-60.
52. Taipale J, Miyazono K, Helkin CH, Keski-Oja J. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994;124: 171-81.
53. Falanga V, Teigs SL, Alstadt SP, Roberts SB, Sporn MB. Transforming growth factor-beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol 1987;89:100-4.
54. McKusik VA. Mendelian inheritance in man: catalogs of genes and genetic disorders. 11th ed. Baltimore: Johns Hopkins University Press; 1994.
55. Eldadah ZA, Brenn T, Furthmayr H, Dietz H. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest 1995;95:874-80.
56. Ramirez F. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr Opin Genet Dev 1996;6:309-15.
57. Milewicz DM, Duvic M. Severe neonatal Marfan syndrome resulting from a de novo 3 bp insertion into the fibrillin gene on chromosome 15. Am J Hum Genet 1994;54:446-53.
58. Putnam EA, Cho M, Zinn AB, Towbin JA, Byers PH, Milewicz DM. Delineation of the Marfan phenotype associated with mutations in exons 23 through 32 of the FBN1 gene. Am J Med Genet 1996;62:233-42.
59. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.